Concepedia

Tiandong Kong

TK

Statistics

Publications

3

Citations

77

H-Index

3

Active since

2020

Affiliations

Zhengzhou People's Hospital(Current)

First Affiliated Hospital of Zhengzhou University

Tiandong Kong is an author at Zhengzhou People's Hospital specializing in cancer therapeutics, lung cancer, and radiation oncology.

ORCID

Top concepts

Publications per year

2020–2022

3

Publications

3

PGAM1, regulated by miR-3614-5p, functions as an oncogene by activating transforming growth factor-β (TGF-β) signaling in the progression of non-small cell lung carcinoma

Fangfang Li, Hao Yang, Tiandong Kong et al. · Cell Death and Disease · 2020 · 45 citations · Full text

Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study

Tiandong Kong, Lu Chen, Xiaoli Zhao et al. · Investigational New Drugs · 2022 · 18 citations

, , +7

Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2)

Wei Zhang, Pengbo Deng, Tiandong Kong et al. · Lung Cancer · 2022 · 14 citations

, , +8

1–3 of 3